NCT07057856View on ClinicalTrials.gov

An Analysis of the Relationship Between the Genetic Polymorphisms of Interleukin 12 Receptor Subunit Beta 1 and Crohn's Disease in Chinese Patients

CompletedOBSERVATIONAL

Enrollment

866

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions

Crohn's Disease

Interventions

BIOLOGICAL

Ustekinumab (UST)

The first sufficient dose of UST (6mg/kg) was administered intravenously at weeks 0

Trial Locations (1)

Unknown

the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou

All Listed Sponsors

lead

Second Affiliated Hospital of Wenzhou Medical University

OTHER

NCT07057856 - An Analysis of the Relationship Between the Genetic Polymorphisms of Interleukin 12 Receptor Subunit Beta 1 and Crohn's Disease in Chinese Patients | Biotech Hunter | Biotech Hunter